Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The effects of chemotherapy on primary small bowel cancer: A retrospective multicenter observational study in Japan.

Mizushima T, Tamagawa H, Mishima H, Ikeda K, Fujita S, Akamatsu H, Ikenaga M, Onishi T, Fukunaga M, Fukuzaki T, Hasegawa J, Takemasa I, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M.

Mol Clin Oncol. 2013 Sep;1(5):820-824. Epub 2013 Jul 22.

2.

Characteristics and Treatment Strategies for Small Bowel Adenocarcinoma in Advanced-stage Cases.

Nakanoko T, Koga T, Taketani K, Hirayama Y, Yoshiya S, Minagawa R, Kai M, Kajiyama K, Maehara Y.

Anticancer Res. 2015 Jul;35(7):4135-8.

PMID:
26124367
3.

Postoperative adjuvant chemotherapy in rectal cancer operated for cure.

Petersen SH, Harling H, Kirkeby LT, Wille-Jørgensen P, Mocellin S.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD004078. doi: 10.1002/14651858.CD004078.pub2. Review.

PMID:
22419291
4.

First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases.

Galizia G, Lieto E, Orditura M, Castellano P, Imperatore V, Pinto M, Zamboli A.

Arch Surg. 2008 Apr;143(4):352-8; discussion 358. doi: 10.1001/archsurg.143.4.352.

PMID:
18427022
5.

Clinical use of molecular targeted agents for primary small bowel adenocarcinoma: A multicenter retrospective cohort study by the Osaka Gut Forum.

Hirao M, Komori M, Nishida T, Iijima H, Yamaguchi S, Ishihara R, Yasunaga Y, Kobayashi I, Kishida O, Oshita M, Hagiwara H, Ito T, Suzuki K, Hayashi Y, Inoue T, Tsujii M, Yoshihara H, Takehara T.

Oncol Lett. 2017 Aug;14(2):1628-1636. doi: 10.3892/ol.2017.6290. Epub 2017 Jun 1.

6.

Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study.

Karoui M, Roudot-Thoraval F, Mesli F, Mitry E, Aparicio T, Des Guetz G, Louvet C, Landi B, Tiret E, Sobhani I.

Dis Colon Rectum. 2011 Aug;54(8):930-8. doi: 10.1097/DCR.0b013e31821cced0. Erratum in: Dis Colon Rectum. 2011 Oct;54(10):1338. DesGuetz, Gaetan [corrected to Des Guetz, Gaetan].

PMID:
21730780
7.

Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer.

Kim CH, Huh JW, Kim HJ, Lim SW, Song SY, Kim HR, Na KJ, Kim YJ.

Dis Colon Rectum. 2012 Apr;55(4):459-64. doi: 10.1097/DCR.0b013e318246b08d.

PMID:
22426271
8.

Prognostic clinicopathological factors after curative resection of small bowel adenocarcinoma.

Inoue Y, Hayashi M, Satou N, Miyamoto Y, Hirokawa F, Asakuma M, Shimizu T, Kayano H, Yamamoto M, Yamana H, Okuda J, Egashira Y, Tanigawa N.

J Gastrointest Cancer. 2012 Jun;43(2):272-8. doi: 10.1007/s12029-011-9290-0.

PMID:
21607548
9.

Clinical significance of adjuvant surgery following chemotherapy for patients with initially unresectable stage IV gastric cancer.

Ito S, Oki E, Nakashima Y, Ando K, Hiyoshi Y, Ohgaki K, Saeki H, Morita M, Sakaguchi Y, Maehara Y.

Anticancer Res. 2015 Jan;35(1):401-6.

PMID:
25550579
10.

Results of aggressive treatment of gastric sarcoma.

Carson W, Karakousis C, Douglass H, Rao U, Palmer ML.

Ann Surg Oncol. 1994 May;1(3):244-51.

PMID:
7531105
11.

Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.

Nakayama I, Suenaga M, Wakatsuki T, Ichimura T, Ozaka M, Takahari D, Shinozaki E, Chin K, Ueno M, Mizunuma N, Yamaguchi T.

Cancer Chemother Pharmacol. 2015 Jul;76(1):133-9. doi: 10.1007/s00280-015-2780-1. Epub 2015 May 21.

PMID:
25994854
12.

Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial.

Yoshimura K, Uehara K, Tojima Y, Kawai S, Mokuno Y, Maeda A, Kyokane T, Kobayashi S, Yoshioka Y, Nagino M.

Trials. 2013 Jan 15;14:17. doi: 10.1186/1745-6215-14-17.

13.

Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.

Niitsu H, Hinoi T, Shimomura M, Egi H, Hattori M, Ishizaki Y, Adachi T, Saito Y, Miguchi M, Sawada H, Kochi M, Mukai S, Ohdan H.

World J Surg Oncol. 2015 Apr 24;13:162. doi: 10.1186/s12957-015-0570-1.

14.

Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer.

Cirocchi R, Trastulli S, Abraha I, Vettoretto N, Boselli C, Montedori A, Parisi A, Noya G, Platell C.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD008997. doi: 10.1002/14651858.CD008997.pub2. Review.

PMID:
22895981
15.

FOLFOX as adjuvant chemotherapy after curative resection of distant metastases in patients with colorectal cancer.

Nozawa H, Kitayama J, Sunami E, Saito S, Kanazawa T, Kazama S, Yazawa K, Kawai K, Mori K, Nagawa H.

Oncology. 2011;80(1-2):84-91. doi: 10.1159/000328761. Epub 2011 Jun 13.

PMID:
21677451
16.

Adjuvant and neoadjuvant therapy for gastric cancer.

Kelsen DP.

Semin Oncol. 1996 Jun;23(3):379-89. Review.

PMID:
8658222
17.

Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Satoi S, Yamaue H, Kato K, Takahashi S, Hirono S, Takeda S, Eguchi H, Sho M, Wada K, Shinchi H, Kwon AH, Hirano S, Kinoshita T, Nakao A, Nagano H, Nakajima Y, Sano K, Miyazaki M, Takada T.

J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):590-600. doi: 10.1007/s00534-013-0616-0.

PMID:
23660962
18.

Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.

Brandi G, Derenzini E, Falcone A, Masi G, Loupakis F, Pietrabissa A, Pinna AD, Ercolani G, Pantaleo MA, Di Girolamo S, Grazi GL, de Rosa F, Biasco G.

Clin Colorectal Cancer. 2013 Sep;12(3):188-94. doi: 10.1016/j.clcc.2013.04.002. Epub 2013 Jun 14.

PMID:
23773458
19.

Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study.

Takahashi T, Shibata Y, Tojima Y, Tsuboi K, Sakamoto E, Kunieda K, Matsuoka H, Suzumura K, Sato M, Naganuma T, Sakamoto J, Morita S, Kondo K.

Int J Clin Oncol. 2013 Apr;18(2):335-42. doi: 10.1007/s10147-012-0382-z. Epub 2012 Mar 2.

PMID:
22383023
20.

Liver resection for colorectal cancer metastases.

Gallinger S, Biagi JJ, Fletcher GG, Nhan C, Ruo L, McLeod RS.

Curr Oncol. 2013 Jun;20(3):e255-65. doi: 10.3747/co.20.1341.

Supplemental Content

Support Center